Learn More
Medchemexpress LLC Ibiglustat succinate | 1629063-80-4 | 99.7% | 507.57 | 2 MG

Supplier: Medchemexpress LLC HY16743B2MG
Ibiglustat succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. It is used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease.
- Orally active
- Brain-penetrant glucosylceramide synthase (GCS) inhibitor
- Can prevent additional GL-3 accumulation in Fabry disease cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.